In people with normal cognition, depressive symptoms and amyloid pathology were not associated with each other (OR 1.13, 95% CI 0.90-1.40, P=0.29), reported Julie Oomens, PhD, of Maastricht ...

An increased amyloid-β load is not a benign result of aging; it is associated with lower cognitive performance and poor ...

Holstege was supported by ABOARD, a public-private partnership receiving funding from ZonMw and Health Holland, Topsector Life Sciences and Health, the Hans und Ilse Breuer Stiftung, the Horstingstuit ...

Alnylam (Nasdaq: ALNY) has secured expanded UK regulatory approval for Amvuttra (vutrisiran), broadening its indication to include treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in adults ...

Since amyloid-beta pathology often precedes tau abnormalities in Alzheimer's disease, most biomarker efforts have focused on early detection of amyloid-beta changes.